0001104659-24-000290.txt : 20240102
0001104659-24-000290.hdr.sgml : 20240102
20240102152343
ACCESSION NUMBER: 0001104659-24-000290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240102
DATE AS OF CHANGE: 20240102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSS GEORGE K
CENTRAL INDEX KEY: 0001068724
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 24502104
MAIL ADDRESS:
STREET 1: 1350 TREAT BLVD
STREET 2: SUITE 250
CITY: WALNUT CREEK
STATE: CA
ZIP: 94596
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0000786947
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 110853640
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
CITY: PALATINE
STATE: IL
ZIP: 60067
BUSINESS PHONE: 847-705-7709
MAIL ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
STREET 2: .
CITY: PALATINE
STATE: IL
ZIP: 60067
FORMER COMPANY:
FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW
DATE OF NAME CHANGE: 19920703
4
1
tm241461-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-02
0
0000786947
ACURA PHARMACEUTICALS, INC
ACUR
0001068724
ROSS GEORGE K
ACURA PHARMACEUTICALS, INC.
616 N. NORTH COURT, SUITE 120
PALATINE
IL
60067
1
0
0
0
0
Common Stock
2024-01-02
4
M
0
50000
A
495503
D
Restricted Stock Units (2021 Plan)
2024-01-02
4
M
0
50000
D
Common Stock
50000
0
D
Restricted Stock Units (2021 Plan)
2024-01-02
4
A
0
50000
D
Common Stock
50000
50000
D
Represents exchange of restricted stock units.
Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
Does not include Restricted Stock Units.
1 - for - 1
50,000 Restricted Stock Units were granted on January 3, 2023. 25% of Restricted Stock Units vested on the last day of each of March, June, September and December 2023. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
N/A
50,000 Restricted Stock Units were granted on January 3, 2024. 25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2024, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2025, or earlier upon a change of control.
/s/ George Ross
2024-01-02